TAF) and simvastatin; a case report

Overview of attention for article published in BMC Nephrology, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 22 X posts from 21 X users, with an upper bound of 33,658 followers.

RT @hivinteractions: Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvast…

RT @hivinteractions: Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvast…

RT @Medinteract: Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin…

RT @Medinteract: Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.